Article
Disease-targeted sequencing: a cornerstone in the clinic.
Nature reviews. Genetics - 1 Apr 2013
Rehm Heidi L
Abstract excerpt
With the declining cost of sequencing and the ongoing discovery of disease genes, it is now possible to examine hundreds of genes in a single disease-targeted test. Although exome- and genome-sequencing approaches are beginning to compete, disease-targeted testing retains certain advantages and still holds a firm place in the diagnostic evaluation. Here I examine the current state of clinical disease-targeted...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
